Stanley Erck
Director/Board Member bei MAXCYTE, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Herr Stanley C. Erck ist President, Chief Executive Officer & Director bei Novavax, Inc. und ein unabhängiger Non-Executive Director bei MaxCyte, Inc. Er ist Mitglied des Board of Directors bei Novavax, Inc., der MdBio Foundation und MaxCyte, Inc. Herr Erck war zuvor als unabhängiger Direktor bei BioCryst Pharmaceuticals, Inc. beschäftigt, als President, Chief Executive Officer & Director bei Iomai Corp., als Head-Global Regulatory Affairs Vaccines bei Baxter International, Inc., als Vice President-Corporate Development bei Integrated Genetics, Inc. und als President, Chief Executive Officer & Director bei Procept, Inc. Er erhielt seinen Bachelor-Abschluss von der University of Illinois und einen MBA von der University of Chicago Booth School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MAXCYTE, INC.
0,24% | 22.06.2023 | 247 751 ( 0,24% ) | 1 Mio $ | 31.03.2024 |
NOVAVAX, INC.
0,03% | 18.04.2023 | 36 492 ( 0,03% ) | 174 432 $ | 31.03.2024 |
Aktive Positionen von Stanley Erck
Unternehmen | Position | Beginn |
---|---|---|
MAXCYTE, INC. | Director/Board Member | 01.01.2005 |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Director/Board Member | 13.05.2009 |
Ehemalige bekannte Positionen von Stanley Erck
Unternehmen | Position | Ende |
---|---|---|
NOVAVAX, INC. | Chief Executive Officer | 23.01.2023 |
BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 03.12.2018 |
IOMAI CORPORATION | Chief Executive Officer | 01.01.2008 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Corporate Officer/Principal | - |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Chief Executive Officer | - |
Ausbildung von Stanley Erck
University of Illinois | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
NOVAVAX, INC. | Health Technology |
MAXCYTE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Health Technology |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Miscellaneous |